Back to dashboard
CommercialCoverageLow impact

08.02.36, Zolbetuximab-clzb (Vyloy®)

Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Apr 21, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

A new commercial policy has been created for Zolbetuximab-clzb (Vyloy®), a specialty pharmacy drug. This establishes coverage criteria and billing guidelines for this medication under commercial insurance plans.

Action Required

Action needed
By April 21, 2025: Billing team should review the full policy details at the provided URL to understand coverage criteria, prior authorization requirements, and billing procedures for Zolbetuximab-clzb (Vyloy®). Update pharmacy billing protocols accordingly if your practice administers specialty medications.

Related policy hubs